Sabby Management’s Xenetic Biosciences XBIO Stock Holding History

Sabby Management’s Portfolio XBIO Stock Details XBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,052	Closed	-$45K	–	125
2020 Q1	$45K	Sell	6,052 -20,498	-77%	-$238K	0.02%	75
2019 Q4	$382K	Sell	26,550 -13,905	-34%	-$177K	0.11%	38
2019 Q3	$484K	Buy	+40,455	New	+$1.45M	0.26%	38

Other funds holding XBIO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Sabby Management's XBIO Position: Q2 2020 in Review

Sabby Management sold out of Xenetic Biosciences (XBIO) in Q2 2020, closing a stake of 6,052 shares — an estimated $45K sold.

Sabby Management first reported a position in XBIO in Q3 2019 and held it in 3 quarters. The position peaked at $484K in Q3 2019. 6 funds tracked by Wall St. Rank hold XBIO as of Q2 2020.

Sabby Management reported no remaining Xenetic Biosciences position as of Q2 2020 after selling out during the quarter.
Sabby Management sold 6,052 Xenetic Biosciences shares in Q2 2020, an estimated $45K.
Sabby Management first reported a position in Xenetic Biosciences in Q3 2019 and held it in 3 quarters.
Sabby Management's Xenetic Biosciences position peaked at $484K in Q3 2019.
6 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q2 2020.

Based on Sabby Management's 13F filing for Q2 2020, filed 14 Aug 2020.